The Damon Runyon Cancer Research Foundation has named four outstanding young scientists to tackle cancers in children and young adults. The award provides funding for basic scientists and clinicians conducting research with the potential to significantly impact pediatric cancer prevention, diagnosis, or treatment.
Damon Runyon Cancer Research Foundation has named 17 new Fellows, awarding over $2.7 million in grants to early-career researchers conducting innovative cancer research. The recipients will work on novel projects aiming to develop more effective treatments for various cancers.
The foundation awarded six new Clinical Investigators, including Omar Abdel-Wahab and Himisha Beltran, for their cancer research programs. The recipients will receive $450,000 each, while three others received Continuation Grants worth $300,000 to support ongoing research.
The foundation awarded 15 Damon Runyon Fellows with $156,000 each to pursue novel ideas in cancer research. The recipients include Adam de la Zerda and Gabriel C. Lander, who aim to visualize signaling within tumors and characterize molecular machines in cells.
The Damon Runyon-Rachleff Innovation Award funds cancer research by exceptionally creative thinkers with 'high-risk/high-reward' ideas, selected through a rigorous process. Seven awardees aim to develop new approaches to fighting cancer, including virus-based treatments and single-cell sequencing tools.
The Damon Runyon Cancer Research Foundation and Sohn Conference Foundation have named three outstanding young scientists as the first-ever Pediatric Cancer Research Fellows. The awardees, Lara E. Davis, Angela J. Sievert, and Leo Wang, will receive $186,000 each to tackle cancers in children and young adults.
The foundation awarded three-year fellowships to postdoctoral scientists conducting basic and translational cancer research, providing them with independent funding to pursue novel projects. Recipients aim to understand molecular mechanisms of gene silencing, cellular cargo transport, and immune system interactions.
The Damon Runyon Cancer Research Foundation awarded $3.3 million to eight promising young clinical investigators, focusing on breast cancer and brain tumors.
The Damon Runyon Cancer Research Foundation launched its Accelerating Cancer Cures program, a five-year initiative to train exceptional clinical investigators and foster collaboration between academia and industry. The program aims to address the critical shortage of clinical researchers working on breakthroughs in cancer treatments an...
Five scientists have been awarded $2.25 million to develop innovative approaches to fighting cancer, including targeting macrophages and biomarkers. The grants aim to improve the prevention, diagnosis, and treatment of cancer.
The foundation awarded $156,000 each to 18 new fellows and $100,000 to three Breakthrough Scientists recipients. The awards support novel ideas in cancer research, enabling the nation's most promising young scientists to pursue careers in cancer research.
The Damon Runyon Cancer Research Foundation and the Sohn Conference Foundation have partnered to support young scientists tackling childhood cancers, with a focus on preventing devastating illnesses in children and young adults. The partnership aims to recruit top young minds to research childhood cancers, leveraging the success of exi...
The Damon Runyon Cancer Research Foundation has awarded prestigious fellowships to 18 outstanding postdoctoral scientists, providing them with independent funding to pursue novel ideas in cancer research. The fellowships will support research into various aspects of cancer, including gene expression, cell growth, and tumor development.
The foundation awarded Clinical Investigator Awards to nine early-career physician-scientists conducting patient-oriented cancer research at major centers. The recipients will receive $450,000 each over three years, while Continuation Grants will provide an additional two years of funding totaling $300,000.
Five scientists with novel approaches to fighting cancer have been awarded the Damon Runyon-Rachleff Innovation Award, receiving a total of $2.25 million over three years. The recipients aim to significantly impact cancer prevention, diagnosis, and treatment through their pioneering ideas.
The Damon Runyon Cancer Research Foundation has awarded grants totaling $1.9M to 12 early-career researchers conducting innovative cancer research. The fellowships provide independent funding to support novel projects and enable recipients to pursue careers in cancer research.
The Damon Runyon Cancer Research Foundation has awarded two researchers, Ken Cadwell and L. Stirling Churchman, with the Dale F. Frey Award for Breakthrough Scientists. They will use the $100,000 funding to pursue innovative research in cancer prevention, diagnosis, and treatment.
The foundation named 18 new Damon Runyon Fellows for their innovative cancer research, including studies on gene regulation, immune response, and tumor development. The recipients will receive $156,000 each to pursue novel ideas.
The Damon Runyon Cancer Research Foundation and Doris Duke Charitable Foundation have partnered to support Tobias J.E. Carling, a young physician-scientist with a $486,000 grant. The foundation aims to address the shortage of talented physician-scientists dedicated to translating research into breakthrough treatments.
The foundation awarded grants to eight young clinical investigators to support their cancer research programs, with a focus on developing new treatments and improving patient quality of life. The awards total $3.1 million and will provide funding for three years, with some recipients also receiving continuation grants.
The foundation provides three-year fellowships with $140,000 each to support groundbreaking projects in basic and translational cancer research. The recipients aim to pursue careers in cancer research by investigating key topics such as epigenetic alterations, protein function, and cellular behavior.
The 2010 awards support groundbreaking research in cancer metabolism, tumor metabolism, and drug resistance. Three scientists will explore novel approaches to fighting cancer using innovative technologies.
The Damon Runyon Cancer Research Foundation has awarded $2.7M to seven young clinical investigators, providing three-year funding and Continuation Grants to support their cancer research programs. The recipients include Andrew L. Feldman, William Y. Kim, C. Ryan Miller, Vu H. Nguyen, Renier J. Brentjens, Patrick A. Brown, and others.
The Damon Runyon Cancer Research Foundation has awarded prestigious fellowships to 17 outstanding postdoctoral scientists conducting innovative cancer research. The fellows will receive $140,000 each to work on projects aimed at improving cancer treatments and diagnostics.
The Damon Runyon Cancer Research Foundation has awarded prestigious three-year fellowships to 13 outstanding postdoctoral scientists conducting basic and translational cancer research. The fellowships aim to encourage promising young investigators to pursue careers in cancer research, providing independent funding for innovative projects.
The 2009 awards recognize groundbreaking work in early detection of ovarian and lung cancers, improvements to bone marrow transplant safety, and discovery of new genetic markers for cancer. The $450,000 prize will support the projects over three years.
The Damon Runyon Cancer Research Foundation has awarded $2.25M to five outstanding young clinical investigators, including Dr. Ronald Buckanovich, Andrew Chan, Rachael Clark, Vassiliki Karantza-Wadsworth, and Elahe Mostaghel, to support their cancer research programs.
The Damon Runyon Cancer Research Foundation has awarded fellowships to 14 promising young scientists conducting innovative cancer research projects. The three-year award provides independent funding to support their work in basic and translational cancer research.
The foundation has committed over $200 million to support cancer researchers since its inception. Seventeen new Damon Runyon Fellows were named for their innovative projects in basic and translational cancer research.
The Damon Runyon Cancer Research Foundation has named 18 new Damon Runyon Fellows, outstanding postdoctoral scientists conducting innovative cancer research. The fellows will receive three-year awards of up to $375,000 to pursue their projects, supporting the nation's most promising young investigators in cancer research.
The Damon Runyon Cancer Research Foundation has renewed its investment in young clinical cancer investigators, providing $2.25 million to support the development of their cancer research programs. Five new awardees will receive funding to investigate various types of cancer, including leukemia, lymphoma, and esophageal cancer.
The Damon Runyon-Rachleff Innovation Award provides seed funding for junior scientists with high-risk, high-reward ideas in cancer research. The program aims to apply a venture capital philosophy to scientific research, investing in fresh perspectives and innovative approaches.